for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

BRIEF-Health Canada approves Novo Nordisk's Tresiba, a new basal insulin for type 1 and 2 diabetes

Aug 28 (Reuters) - Novo Nordisk A/S

* Health Canada approves Tresiba®, a new basal insulin for type 1 and 2 diabetes

* Novo Nordisk Canada Inc - Health Canada has approved Tresiba Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up